CH
Carsten Herskind
Medizinische Fakultät Mannheim, Heidelberg University, Aarhus University
Research areas: Physics and Astronomy · Radiation · Effects of Radiation Exposure · Radiation Therapy and Dosimetry · Advanced Radiotherapy Techniques
Employment
-
Universität Heidelberg Medizinische Fakultät Mannheim Joint head, Cellular and Molecular Radiation Oncology Lab2022 - Present
-
Universität Heidelberg Medizinische Fakultät Mannheim Head, Cellular and Molecular Radiation Oncology Lab2002 - 2022
Education
-
Heidelberg University Dr. habil.2010 - Present
-
Aarhus Universitet lic. scient. (Ph.D.)1980 - 1984
-
Aarhus Universitet none (passed courses equiv. to B.Med.Sci.)1976 - 1980
-
Aarhus Universitet cand. scient. (M.Sc.)1972 - 1979
Projects & Funding
Projects & funding information is unavailable.
Publications (105)
- FLASH radiotherapy: physico-chemical considerations on ionisation tracks, radical reactions, and the role of oxygen Save
- Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer Save
- Selective inhibitors of bromodomain BD1 and BD2 of BET proteins modulate radiation‐induced profibrotic fibroblast responses Save
- Targeting Cell Cycle Checkpoint Kinases to Overcome Intrinsic Radioresistance in Brain Tumor Cells Save
- A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort Save
- Caveolin-1 regulates the ASMase/ceramide-mediated radiation response of endothelial cells in the context of tumor–stroma interactions Save
- Efficient uptake and retention of iron oxide-based nanoparticles in HeLa cells leads to an effective intracellular delivery of doxorubicin Save
- Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients Save
- Targeting the Post-Irradiation Tumor Microenvironment in Glioblastoma via Inhibition of CXCL12 Save
- A HYPOTHESIS of RADIORESISTANCE and CELL-SURVIVAL CURVE SHAPE BASED on CELL-CYCLE PROGRESSION and DAMAGE TOLERANCE Save
- Association of CD4 þ radiation-induced lymphocyte apoptosis with fibrosis and telangiectasia after radiotherapy in 272 breast cancer patients with >10-year follow-up Save
- Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma (INTRAGO): An open-label, dose-escalation Phase I/II trial Save
- Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity Save
- Radiation-induced malignancies after intensity-modulated versus conventional mediastinal radiotherapy in a small animal model Save
- Radiotherapy, tumor mutational burden, and immune checkpoint inhibitors: time to do the math Save
- BET-bromodomain inhibitors modulate epigenetic patterns at the diacylglycerol kinase alpha enhancer associated with radiation-induced fibrosis. Save
- Smart Radiation Therapy Biomaterials. Save
- Biology of high single doses of IORT: RBE, 5 R's, and other biological aspects. Save
- Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance. Save
- Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection. Save